Loading…

ED-20 THE INCIDENCE OF PEDIATRIC BRAIN TUMORS WITHIN THE SCOTT AND WHITE INTEGRATED HEALTHCARE HEALTH SYSTEM

INTRODUCTION: Pediatric brain tumors are the second most common childhood tumor. The purpose of this study was to determine how the outcome of pediatric brain tumor is affected by different factors such as age, geographic location, brain tumor type, tumor grade and ethnicity. METHODS: We conducted a...

Full description

Saved in:
Bibliographic Details
Published in:Neuro-oncology (Charlottesville, Va.) Va.), 2014-11, Vol.16 (suppl 5), p.v70-v70
Main Authors: Mukherjee, S., peddaboina, C. S., Ebwe, E., Udaikumar, J., Shephard, R., Newell-Rogers, K., Singel, S., Fonkem, E.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:INTRODUCTION: Pediatric brain tumors are the second most common childhood tumor. The purpose of this study was to determine how the outcome of pediatric brain tumor is affected by different factors such as age, geographic location, brain tumor type, tumor grade and ethnicity. METHODS: We conducted a retrospective analysis of pediatric brain patient with the Scott and White brain tumor registry from 1978-2011. Data was analyzed based on age, race, treatment year, residential areas and tumor types. Univarate and multivariable survival analyses were performed, in addition to SAS 9.2. RESULTS: There were 159 patients treated within Scott and White brain tumor registry 1978-2011. The median survival time of the combination of the 5 tumor types (N = 101) is 147.12 months (95% CI (79.61-260.73)). The median survival times and concurrent 95% confidence intervals of pilocytic Astrocytomas, Ependymomas, malignant Gliomas, medulloblastomas, and oligodendrogliomas are respective and as follows: no available survival time with 95% CI 109.04 months; median survival of 182.51 mo and 95% CI 15.28mo; median survival of 14.26 mo and 95% CI 11.70 mo; median survival of 115.35 mo and 95% CI (22.70-260.73 mo); median survival not available with 95% CI 5.52 mo. The median of the follow-up time of the combination of the 5 tumor types (N = 101) is 104 months. For the patients who survived (N = 58), the median of the follow-up time is 73.17 months, the minimum is 3.06 months, and the maximum is 298.61 months. Finally, with an increase in age, we observed a concurrent increase in median survival time. We observed no difference among other factors. CONCLUSION: This study suggests that pediatric brain tumors are frequently diagnosed within the Scott & White Integrated Health Care System. Patient age was associated with increased survival time while other factors such as race/ethnicity were not.
ISSN:1522-8517
1523-5866
DOI:10.1093/neuonc/nou253.20